CEQUA

Peak

cyclosporine

NDAOPHTHALMICSOLUTION
Approved
Aug 2018
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20

Mechanism of Action

Calcineurin Inhibitors

Pharmacologic Class:

Calcineurin Inhibitor Immunosuppressant

Clinical Trials (5)

NCT06837259Phase 1Completed

A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults

Started Mar 2025
26 enrolled
Healthy Adults
NCT05946772Phase 2Recruiting

Cyclosporine In Takotsubo Syndrome

Started Feb 2025
204 enrolled
Takotsubo Cardiomyopathy
NCT06541678Phase 1Completed

A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.

Started Dec 2024
16 enrolled
Healthy
NCT05745701Phase 1Completed

A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults

Started Feb 2023
16 enrolled
Healthy
NCT05573230Phase 1Completed

A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants

Started Oct 2022
32 enrolled
Healthy

Loss of Exclusivity

LOE Date
Feb 28, 2037
133 months away
Patent Expiry
Feb 28, 2037

Patent Records (5)

Patent #ExpiryTypeUse Code
10441630
Aug 23, 2033
Product
8980839
Aug 23, 2033
Product
U-1483
9937225
Aug 23, 2033
Product
U-1483
10918694
Feb 28, 2037
Product
11951153
Feb 28, 2037
U-1483